Nicotine as a typical drug of abuse in experimental animals and humans

被引:91
|
作者
Le Foll, B [1 ]
Goldberg, SR [1 ]
机构
[1] NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA
关键词
D O I
10.1007/s00213-005-0155-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale and background: Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but reinforcing effects of nicotine often are difficult to demonstrate directly in controlled laboratory studies with animal or human subjects. Objective: To review the major findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans, i.e., drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination, withdrawal signs, and ratings of drug withdrawal. Results: Nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Further experiments are also needed to delineate the role other chemical substances inhaled along with nicotine in tobacco smoke play in sustaining smoking behavior. Conclusions: Nicotine acts as a typical drug of abuse in experimental animals and humans.
引用
收藏
页码:367 / 381
页数:15
相关论文
共 50 条
  • [31] Drug counselor report of adolescents abuse of nicotine replacement therapy
    Hyland, A
    Bradford, D
    Gitchell, J
    JOURNAL OF ADDICTIVE DISEASES, 2005, 24 (04) : 105 - 113
  • [32] DRUG INFLUENCES ON LEARNING AND MEMORY IN AGED ANIMALS AND HUMANS
    HOCK, FJ
    NEUROPSYCHOBIOLOGY, 1987, 17 (03) : 145 - 160
  • [33] Experimental Study on Animals on the Nicotine harm of the Central Nervous System
    Stief, A.
    Huszak, St.
    MONATSSCHRIFT FUR PSYCHIATRIE UND NEUROLOGIE, 1937, 95 (01): : 36 - 42
  • [34] EFFECTS OF NICOTINE ON CONDITIONED AND UNCONDITIONED BEHAVIORS IN EXPERIMENTAL-ANIMALS
    HENDRY, JS
    ROSECRANS, JA
    PHARMACOLOGY & THERAPEUTICS, 1982, 17 (03) : 431 - 454
  • [35] The developmental toxicity of phytoestrogens in experimental animals: are there concerns for humans?
    Sheehan, DM
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06): : 1543S - 1543S
  • [36] A common approach to experimental pain in both humans and animals
    Le Bars, D.
    Pollin, B.
    Plaghki, L.
    DOULEUR ET ANALGESIE, 2011, 24 (04): : 227 - 236
  • [37] Bridging the Gap Between Experimental Animals and Humans in Osteosarcoma
    Withrow, Stephen J.
    Khanna, Chand
    PEDIATRIC AND ADOLESCENT OSTEOSARCOMA, 2009, 152 : 439 - +
  • [38] Drugs to Foster Kidney Regeneration in Experimental Animals and Humans
    Gagliardini, Elena
    Benigni, Ariela
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2014, 126 (02): : 91 - 96
  • [39] COMPARATIVE METABOLISM OF ASPARTAME IN EXPERIMENTAL-ANIMALS AND HUMANS
    RANNEY, RE
    OPPERMANN, JA
    MULDOON, E
    MCMAHON, FG
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1976, 2 (02): : 441 - 451
  • [40] Movement as an index of anesthetic depth in humans and experimental animals
    Antognini, JF
    Barter, L
    Carstens, E
    COMPARATIVE MEDICINE, 2005, 55 (05) : 413 - 418